tiprankstipranks
BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
US Market

BioAge Labs, Inc. (BIOA) Income Statement

Compare
66 Followers

BioAge Labs, Inc. Income Statement

Last quarter (Q3 2024), BioAge Labs, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q3, BioAge Labs, Inc.'s net income was $-23.41M. See BioAge Labs, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00
Operating Expenses
$ 48.40M$ 39.97M
Depreciation and Amortization
$ 162.00K$ 129.00K
EBITDA
$ -45.81M$ -39.38M
Operating Income
$ -48.40M$ -39.97M
Other Income/Expenses
$ -15.45M$ 247.00K
Pretax Income
$ -63.85M$ -39.72M
Net Income
$ -63.85M$ -39.72M
Per Share Metrics
$ ―$ ―
Basic EPS
$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00
Weighted Average Shares Outstanding
0.00 0.00
Weighted Average Shares Outstanding (Diluted)
0.00 0.00
Currency in USD

BioAge Labs, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis